Syra Health Corp. (SYRA)
OTCMKTS
· Delayed Price · Currency is USD
0.0691
+0.0016 (2.32%)
At close: Dec 5, 2025
Syra Health Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Cash & Equivalents | 1.98 | 2.4 | 3.28 | 0 | 0.1 | 0 |
| Cash & Short-Term Investments | 1.98 | 2.4 | 3.28 | 0 | 0.1 | 0 |
| Cash Growth | -26.73% | -26.97% | 97988.37% | -96.66% | 3233.73% | - |
| Accounts Receivable | 0.93 | 0.68 | 1.06 | 1.2 | 0.26 | - |
| Other Receivables | - | - | 0.07 | 0.15 | 0.02 | - |
| Receivables | 0.93 | 0.68 | 1.13 | 1.35 | 0.28 | - |
| Prepaid Expenses | 0.31 | 0.28 | 0.32 | 0.05 | - | - |
| Other Current Assets | - | - | 0.05 | 0.03 | - | - |
| Total Current Assets | 3.21 | 3.35 | 4.78 | 1.43 | 0.38 | 0 |
| Property, Plant & Equipment | 0.05 | 0.33 | 0.14 | 0.3 | 0.15 | - |
| Long-Term Deferred Charges | - | - | - | 0.6 | - | - |
| Total Assets | 3.26 | 3.68 | 4.92 | 2.32 | 0.54 | 0 |
| Accounts Payable | 0.46 | 0.1 | 0.46 | 0.43 | 0.13 | - |
| Accrued Expenses | 0.22 | 0.23 | 0.2 | 0.24 | 0.05 | 0 |
| Short-Term Debt | 0.19 | 0.15 | 0.18 | 0.75 | 0.19 | 0 |
| Current Portion of Leases | 0.04 | 0.11 | 0.06 | 0.12 | 0.06 | - |
| Current Unearned Revenue | 0.14 | 0.02 | - | - | - | - |
| Other Current Liabilities | - | - | - | - | 0.03 | - |
| Total Current Liabilities | 1.05 | 0.61 | 0.91 | 1.55 | 0.45 | 0.01 |
| Long-Term Leases | - | 0.19 | - | 0.06 | 0.09 | - |
| Total Liabilities | 1.05 | 0.8 | 0.91 | 1.61 | 0.54 | 0.01 |
| Common Stock | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 |
| Additional Paid-In Capital | 11.78 | 11.69 | 9.07 | 2.83 | 0 | - |
| Retained Earnings | -9.59 | -8.82 | -5.06 | -2.13 | -0.01 | -0.01 |
| Shareholders' Equity | 2.21 | 2.88 | 4.01 | 0.71 | -0.01 | -0 |
| Total Liabilities & Equity | 3.26 | 3.68 | 4.92 | 2.32 | 0.54 | 0 |
| Total Debt | 0.23 | 0.45 | 0.25 | 0.93 | 0.34 | 0 |
| Net Cash (Debt) | 1.74 | 1.94 | 3.03 | -0.93 | -0.24 | - |
| Net Cash Growth | -18.18% | -35.91% | - | - | - | - |
| Net Cash Per Share | 0.15 | 0.26 | 0.62 | -0.08 | -0.02 | - |
| Filing Date Shares Outstanding | 17.34 | 17.31 | 14.06 | 11.9 | 11.9 | 13.75 |
| Total Common Shares Outstanding | 17.34 | 17.31 | 13.92 | 11.9 | 8.33 | 13.75 |
| Working Capital | 2.16 | 2.74 | 3.87 | -0.12 | -0.07 | -0 |
| Book Value Per Share | 0.13 | 0.17 | 0.29 | 0.06 | -0.00 | -0.00 |
| Tangible Book Value | 2.21 | 2.88 | 4.01 | 0.71 | -0.01 | -0 |
| Tangible Book Value Per Share | 0.13 | 0.17 | 0.29 | 0.06 | -0.00 | -0.00 |
| Machinery | 0.09 | 0.09 | 0.08 | 0.13 | 0.01 | - |
| Leasehold Improvements | 0.06 | 0.06 | 0.06 | - | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.